Therapeutic Oligonucleotides Overview
Therapeutics oligonucleotides (oligos) have emerged as an area of particular interest and promise in biopharmaceutical development because of their potential to treat a wide range of diseases. These oligos can range in size, sequence complexity, and overall modifications. Synthetic oligonucleotide therapeutics, such as antisense oligonucleotides (ASOs) and small interfering RNAs (si-RNAs), require thorough analysis to establish intended purity and quality.
Agilent Solutions
Advance Your Lead Oligonucleotide from Discovery to Market - Invest in a proven superior solution, services provider offering multi-application capabilities with a diverse compliant ready portfolio solution and world-class innovation to enable cost-effective manufacturing of commercial-scale quantities of synthetic oligonucleotides.
AGILENT OLIGONUCLEOTIDES END-TO-END WORKFLOW SOLUTIONS
Oligo Purity Analysis | Oligo Target Plus Impurity Analysis | Oligo Sequence Confirmation | Oligo Purification | Oligo Raw Material Identification | Trace Elemental Impurities | Residual Solvent Analysis | Oligo API Manufacturing
AGILENT OLIGONUCLEOTIDES WORKFLOW PRODUCTS
